HIV - 1 MN gp160 Fragment 13

HIV-1 MN gp160 Fragment 13 displays structural features relevant to intermediate folding states. Its sequence supports mapping of solvent exposure and turn events. Researchers evaluate conformational ensembles to track domain separation. The peptide contributes to precursor-structure modeling.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.

CAT No: H09700

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.W/Mr.
2130.4
Sequence
EGTIKGGEMKNCSFNITTSI
Length
20

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Peptide CDMOPeptide Nucleic Acids SynthesisEpitope Mapping ServicesPeptide Analysis ServicesPeptide Modification ServicesPeptide Synthesis ServicesCustom Conjugation ServicecGMP Peptide Service
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers